Nuclear Medicine


The Division offers traditional nuclear medicine techniques as well as new diagnostic exams.

Our Activities

The Division of Nuclear Medicine is certified ISO 9001-2008 and is devoted to the early localization and treatment of tumors, by means of functional imaging and
targeted radionuclide therapy.

The Division offers traditional nuclear medicine techniques as well as new diagnostic exams, such as sentinel node lymphoscintigraphy in breast, gynecologic, tongue cancer and melanoma, radioguided occult lesion localisation (ROLL) in breast, lung and colon lesions, perfusion procedures in melanoma and sarcoma patients, peptide-guided whole body scans and PET scans. 18FDG-PET scans are routinely performed in the diagnosis, staging, follow up and radiotherapy planning of various types of
cancer, applying ROL criteria in PET/CT scan acquisition.

SinceJuly 2008 PET/TC scans with 68Ga-octreotide are performed. The Division is one of the few in Europe having protocols of radionuclide therapy of solid tumors and lymphomas with new radiolabelled molecules that show high affinity for tumor cells, such as monoclonal antibodies and radiolabelled peptides.

The Division has been one of the pioneers in the development of peptide receptor radionuclide therapy (PRRT) in NETs, where clinical studies have been carried out for over 15 years. Currently it is participating to an international registrative phase III study on PRRT. In 2013, 9685 diagnostic studies were performed, of which 4127 were PET/CT with 18FDG and 482 with 68Ga-octreotide, and over 650 outpatients were visited.



Università degli Studi di Milano Ecancer Medical Science IFOM-IEO Campus


Ministero della Salute Joint Commission International Breastcertification bollinirosa

© 2013 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153


facebook IEO googleplus IEO twitter IEO pinterest IEO vimeo IEO